Does Medicare Cover Ozempic in 2026?

The short answer is yes — but only for specific conditions, and almost always only after prior authorization. Here's what you need to know before calling your plan.

By Alex Carter, Medicare benefits specialist · Published June 28, 2026 · Reviewed June 28, 2026

Ozempic (semaglutide, made by Novo Nordisk) is one of the most prescribed GLP-1 medications in the United States, and one of the most searched questions among Medicare beneficiaries is whether their plan will pay for it. The answer depends on why your doctor is prescribing it, which Part D plan you have, and whether your plan's prior authorization process goes smoothly. This guide walks through every piece of that puzzle.

The quick answer

Medicare Part D covers Ozempic when it is prescribed for type 2 diabetes or a qualifying cardiovascular indication. It is generally not covered when prescribed for weight loss alone. Almost all plans require prior authorization first.

Which Medicare part covers Ozempic?

Ozempic is a self-injected medication — you use a pre-filled pen at home, not in a doctor's office. That means it falls under Medicare Part D (prescription drug coverage), not Part B. If you have a standalone Part D plan alongside Original Medicare, or a Medicare Advantage plan that includes drug coverage, that is the benefit you need to activate.

Part B covers certain drugs administered in a clinical setting. Ozempic, like most GLP-1 injectable pens, is a Part D drug. Confirm this with your plan, since some newer formulations or administration routes could differ.

When does Medicare cover Ozempic?

Covered

  • Type 2 diabetes — the primary approved indication and the most common coverage pathway under Part D.
  • Cardiovascular risk reduction — Ozempic has an FDA approval to reduce the risk of major cardiovascular events (heart attack, stroke, cardiovascular death) in adults with type 2 diabetes and established heart disease.

Not covered

  • Weight loss alone — Part D historically barred drugs used solely for weight management. If there is no diabetes or cardiovascular indication documented, most plans will deny Ozempic.
  • Off-label uses — any use not supported by an approved indication is unlikely to pass prior authorization.

Source: FDA.gov — Ozempic approved indications; CMS.gov — Part D coverage rules. Coverage is illustrative; verify with your plan.

Prior authorization: what to expect

Almost every Part D plan that covers Ozempic requires prior authorization (PA) before they will pay for it. Your prescriber submits a PA request to your plan that typically includes your diabetes diagnosis, a recent A1C value, and sometimes evidence that you tried at least one other diabetes medication first (step therapy). The plan then has up to 72 hours to make a standard coverage determination, or 24 hours for an expedited request if a delay would seriously harm your health.

If the PA is approved, your plan covers Ozempic and you pay only your cost-sharing — usually a copay or coinsurance based on which tier the drug sits on in your formulary. If it is denied, you have the right to appeal. See our prior authorization denied guide for step-by-step appeal instructions.

How much will Ozempic cost me under Medicare?

The retail (cash) price of Ozempic regularly exceeds $1,000 per month. With an approved PA under Part D, your actual cost drops dramatically — to whatever your plan's copay or coinsurance is for the drug's formulary tier. Many beneficiaries pay between $40 and $150 per month, depending on their plan and benefit phase.

Because of the Inflation Reduction Act, Medicare Part D now has an annual out-of-pocket cap on covered drugs. Once you reach that cap (check the current amount at CMS.gov), you pay $0 for covered drugs for the rest of the year. That makes Ozempic significantly more affordable for people who take it long-term. Use our cost calculator to estimate your out-of-pocket for the year.

Does Medicare cover Ozempic for weight loss?

This is one of the most common questions — and the answer is generally no. If your only reason for taking Ozempic is weight management, most Part D plans will not cover it. The drug's FDA indication for type 2 diabetes (or cardiovascular risk) is what unlocks Part D coverage. If weight loss is your primary goal, your doctor may discuss Wegovy (the same drug at a higher dose, approved for obesity) — but Wegovy's coverage pathway under Medicare is different and often narrower. See our Ozempic vs. Wegovy guide for a full comparison.

How to check if your plan covers Ozempic

  1. Find your plan's formulary. Log in to your plan's website or call the member services number on the back of your insurance card. Search for "semaglutide" or "Ozempic."
  2. Note the tier and PA requirements. Ozempic is typically on a higher tier with a prior authorization requirement.
  3. Ask your doctor to submit the PA. Provide your doctor's office with your plan name, member ID, and the drug name. They handle the submission.
  4. Track the request. You and your doctor should both receive a decision within 72 hours (or 24 hours if expedited).
  5. Appeal if denied. A denial is not final. See our appeal guide for next steps.

See if you qualify for GLP-1 coverage

The eligibility check takes about a minute and tells you which coverage pathway fits your situation.

Check my eligibility →

Disclaimer: GLP1Bridge.com is an independent informational resource and is not affiliated with, endorsed by, or operated by Medicare, CMS, or any drug manufacturer. This article is general education, not medical, legal, or financial advice. Coverage rules and figures can change — verify specifics with your plan and CMS.gov.